Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities.
Wang XY, Zhu WW, Wang Z, Huang JB, Wang SH, Bai FM, Li TE, Zhu Y, Zhao J, Yang X, Lu L, Zhang JB, Jia HL, Dong QZ, Chen JH, Andersen JB, Ye D, Qin LX.
Wang XY, et al. Among authors: zhang jb.
Theranostics. 2022 Jan 1;12(1):260-276. doi: 10.7150/thno.63417. eCollection 2022.
Theranostics. 2022.
PMID: 34987644
Free PMC article.